Dupont Capital Management Corp Vericel Corp Transaction History

Dupont Capital Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$47.2 - $67.81 $541,997 - $778,662	-11,483 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$30.93 - $59.48 $72,871 - $140,134	-2,356 Reduced 17.02%	11,483 $638,000
Q4 2020 Jan 28, 2021	SELL	$18.53 - $31.5 $19,141 - $32,539	-1,033 Reduced 6.95%	13,839 $427,000
Q3 2020 Oct 29, 2020	SELL	$14.68 - $19.12 $14,635 - $19,062	-997 Reduced 6.28%	14,872 $276,000
Q2 2020 Jul 24, 2020	BUY	$8.5 - $15.82 $134,886 - $251,047	15,869 New	15,869 $219,000
Q2 2019 Jul 30, 2019	SELL	$15.01 - $18.89 $296,687 - $373,379	-19,766 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$10.77 - $18.44 $212,879 - $364,485	19,766 New	19,766 $344,000

275

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.